Blurbs

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cooper Co (COOResearch Report), Jazz Pharmaceuticals (JAZZResearch Report) and Mettler-Toledo (MTDResearch Report) with bullish sentiments.

Cooper Co (COO)

In a report issued on January 27, Jonathan Block from Stifel Nicolaus maintained a Buy rating on Cooper Co, with a price target of $380.00. The company’s shares closed last Friday at $344.48.

According to TipRanks.com, Block is a 5-star analyst with an average return of 12.8% and a 57.7% success rate. Block covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Envista Holdings, and DENTSPLY SIRONA.

Cooper Co has an analyst consensus of Moderate Buy, with a price target consensus of $365.50, a 5.4% upside from current levels. In a report issued on January 24, Mizuho Securities also maintained a Buy rating on the stock with a $385.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Jazz Pharmaceuticals (JAZZ)

In a report issued on January 27, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Jazz Pharmaceuticals, with a price target of $225.00. The company’s shares closed last Friday at $155.57.

According to TipRanks.com, Samimy is a 4-star analyst with an average return of 9.0% and a 51.3% success rate. Samimy covers the Healthcare sector, focusing on stocks such as Supernus Pharmaceuticals, Bausch Health Companies, and Prometheus Biosciences.

Jazz Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $198.36, a 27.6% upside from current levels. In a report issued on January 20, BMO Capital also maintained a Buy rating on the stock with a $188.00 price target.

Mettler-Toledo (MTD)

In a report issued on January 27, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Mettler-Toledo, with a price target of $1700.00. The company’s shares closed last Friday at $1529.75, close to its 52-week high of $1583.39.

According to TipRanks.com, Arias is a 3-star analyst with an average return of 1.5% and a 53.6% success rate. Arias covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, Guardant Health, and NanoString Tech.

Currently, the analyst consensus on Mettler-Toledo is a Moderate Buy with an average price target of $1486.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on COO:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More